Wnt/β-catenin signaling has been demonstrated to play an important role in bladder cancer progression [15] and studies indicated that DLX6-AS1 regulated bladder cancer progression via Wnt/β-catenin signaling in pancreatic cancer [19]. The gene discussed is DLX6; the disease is urinary bladder cancer.